Shares of Cellceutix Corp. (CTIX.OB) jumped more than 14% on Wednesday following the receipt of the FDA’s Orphan Drug Designation by the company’s drug candidate Kevetrin for the treatment of ovarian cancer.
Forex – financial instrument.Forex news
Shares of Cellceutix Corp. (CTIX.OB) jumped more than 14% on Wednesday following the receipt of the FDA’s Orphan Drug Designation by the company’s drug candidate Kevetrin for the treatment of ovarian cancer.